|
Academic Year: | 2016/7 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | CW100 |
Assessment Detail: |
|
Supplementary Assessment: |
|
Requisites: | |
Description: | Aims: To update knowledge on polypharmacy and reduce associated risks such as adverse drug reactions. To appraise the tools available to manage polypharmacy to reduce risk and adverse outcomes such as avoidable hospital admissions. Develop consultation skills to consider the ethical challenges of de-prescribing. To enable pharmacists to apply medicines optimisation to support patients on multiple medicines. Learning Outcomes: On successful completion of this unit students will be able to: 1. Explain the different types of adverse drug reactions and drug interactions and apply this knowledge to minimise risks associated with polypharmacy. (Medicines Optimisation Tool [MOT]) 2. Discuss the co-morbidities, patient factors and drugs likely to increase risk of adverse drug reactions and how to minimise these risks through appropriate monitoring or review. (MOT) 3. Critically evaluate the currently available screening tools and resources for managing the risks associated with polypharmacy. (MOT; Portfolio) 4. Demonstrate a systematic approach to medication reviews of patients with multiple co-morbidities and polypharmacy. (MOT; Portfolio) 5. Demonstrate good communication and patient centred consultation skills to approach the ethical decisions regarding de-prescribing. (Case Based Discussion [CBD], MOT) 6. Identify times of high risk in patient care and apply medicines optimisation within multidisciplinary care pathways to improve patient outcomes. (MOT, Clinical Activity Reflective Exercise [CARE]) Skills: * Planning & organisation * Basic clinical examination skills * Consultation and communication skills * Study skills * Handling information * Problem solving * Working with others * Leadership skills * Written communication * Improving learning and performance * Reflective practice * Information & communication technology. Content: Defining polypharmacy Adverse drug reactions and interactions Reducing hospital admissions Identification of high risk patients and high risk drugs - multiple co-morbidities Falls risk Tools for managing polypharmacy De-prescribing - difficult discussions and ethical decisions Transfer of Care - a high risk time Pharmacy services to support medicines optimisation in polypharmacy - medicines review and medicines reconciliation Evidence-based polypharmacy. |
Programme availability: |
PA50339 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|